High Efficacy of Praziquantel in Schistosoma haematobium-Infected Children in Taraba State, Northeast Nigeria: A follow-up study

High Efficacy of Praziquantel in Schistosoma haematobium-Infected Children in Taraba State, Northeast Nigeria: A follow-up study

Objectives: This study aimed to assess the efficacy of praziquantel in reducing urinary schistosomiasis prevalence, parasite burden and morbidity rates among a previously reported sample of Schistosoma haematobium-infected children. In addition, predisposing factors for reinfection one year post-tre...

Full description

Bibliographic Details
Main Authors:	Robert S. Houmsou, Binga E. Wama, Hemen Agere, John A. Uniga, Elizabeth U. Amuta, Santaya L. Kela
Format:	Article
Language:	English
Published:	Sultan Qaboos University 2018-12-01
Series:	Sultan Qaboos University Medical Journal
Online Access:	https://journals.squ.edu.om/index.php/squmj/article/view/2850

Similar Items

Integrated control of river and pond water as an exposure source to urogenital schistosomiasis of rural inhabitants in southern Taraba State, Nigeria
by: Robert Soumay Houmsou, et al.
Published: (2021-07-01)

Exactitud diagnóstica de la técnica Schistosoma ICT IgG-IgM frente a otras técnicas de detección de esquistosomiasis urinaria en Nigeria
by: Houmsou Robert Soumay, et al.
Published: (2021-02-01)

Use of rivers' water, inadequate hygiene, and sanitation as exposure of internally displaced persons (IDPs) to urogenital schistosomiasis and soil-transmitted helminthiasis in Jalingo Local Government Area (LGA), Taraba State, Nigeria
by: Wama Emmanuel Binga, et al.
Published: (2022-11-01)

Diagnostic accuracy of Schistoso ma ICT Ig G - IgM and comparison to other used techniques screening urinary schistosomiasis in Nigeria
by: Houmsou Robert Soumay, et al.
Published: (2021-02-01)

Spatial features of malaria in the lowland and nearby highland areas of Taraba State, Nigeria
by: L.C. Garba, et al.
Published: (2023-11-01)

Cross-sectional study and spatial distribution of schistosomiasis among children in Northeastern Nigeria
by: Robert Soumay Houmsou, et al.
Published: (2016-06-01)

Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
by: Jennifer Keiser, et al.
Published: (2014-07-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: G.C. Coles, et al.
Published: (2001-12-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: Charles H. King, et al.
Published: (2000-12-01)

Malarial infection among antenatal and maternity clinics attendees at the Federal Medical Centre, Makurdi, Benue State, Nigeria
by: Elizabeth Amuta, et al.
Published: (2014-02-01)

Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children.
by: Mahamadou S Sissoko, et al.
Published: (2009-10-01)

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa
by: Iran Mendonça da Silva, et al.
Published: (2005-07-01)

Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium
by: Chalotte Willemann Stecher, et al.
Published: (2017-11-01)

Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon
by: Calvin Bisong Ebai, et al.
Published: (2017-12-01)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
by: Jana Kovač, et al.
Published: (2017-08-01)

Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
by: Jean T Coulibaly, et al.
Published: (2012-01-01)

<it>Schistosoma haematobium</it> infections among schoolchildren in central Sudan one year after treatment with praziquantel
by: Ahmed Abedaziz M, et al.
Published: (2012-06-01)

Schistosoma haematobium
by: Cristina Corsini Campioli, et al.
Published: (2023-01-01)

Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011-05-01)

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
by: Bridget W Kimani, et al.
Published: (2018-10-01)

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
by: Jean Claude Dejon-Agobé, et al.
Published: (2019-12-01)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
by: Beatrice Barda, et al.
Published: (2016-09-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya--Reply to Drs. Coles, Liang, and Doenhoff
by: C. H. King, et al.
Published: (2001-12-01)

Dynamics of <it>Schistosoma haematobium </it>egg output and associated infection parameters following treatment with praziquantel in school-aged children
by: Stete Katarina, et al.
Published: (2012-12-01)

Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
by: Jean Claude Dejon-Agobé, et al.
Published: (2021-06-01)

Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
by: Samuel Nkansah Darko, et al.
Published: (2020-05-01)

SCHISTOSOMA HAEMATOBIUM INFECTION AMONG CHILDREN OF ANAM COMMUNITY, SOUTH-EASTERN NIGERIA
by: J. I. Chikwendu, et al.
Published: (2022-05-01)

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection
by: T Mduluza, et al.
Published: (2001-09-01)

Population Genetic Structure and Hybridization of <i>Schistosoma haematobium</i> in Nigeria
by: Amos Mathias Onyekwere, et al.
Published: (2022-03-01)

Experimental Schistosoma haematobium pulmonary hypertension
by: Biruk Kassa, et al.
Published: (2024-01-01)

CRISPR-assisted test for Schistosoma haematobium
by: Dounia Cherkaoui, et al.
Published: (2023-03-01)

Colon polyps in Schistosoma haematobium schistosomiasis
by: Celso Alberto Chassot, et al.
Published: (1998-01-01)

Schistosoma haematobium Infection and Buruli Ulcer
by: Janet T. Scott, et al.
Published: (2004-03-01)

The usefulness of indirect diagnostic tests for Schistosoma haematobium infection after repeated rounds of mass treatment with praziquantel in Mpwapwa and Chakechake districts in Tanzania
by: Billy Ngasala, et al.
Published: (2020-01-01)

Population genetic structure of Schistosoma haematobium and Schistosoma haematobium × Schistosoma bovis hybrids among school-aged children in Côte d’Ivoire
by: Angora Etienne K., et al.
Published: (2022-01-01)

Spatial distribution and ecology of soil parasites and Schistosoma haematobium infection in Eggua, Nigeria
by: Taiwo A Adekeye, et al.
Published: (2021-10-01)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
by: Eglal I. Amer, et al.
Published: (2022-03-01)

Future schistosome hybridizations: Will all Schistosoma haematobium hybrids please stand-up!
by: J Russell Stothard, et al.
Published: (2020-07-01)

Tiv-jakun ethnic conflict in wukari district of taraba state northeast Nigeria: Horizontal inequalities approach
by: Joshua, Ruth Yohanna
Published: (2017)

Genetic manipulation of Schistosoma haematobium, the neglected schistosome.
by: Gabriel Rinaldi, et al.
Published: (2011-10-01)